Efficacy and Safety of LY01005 in Patients With Breast Cancer Compared to ZOLADEX®

Summary

This is a multicenter, randomized, open-label, active comparator-controlled phase Ⅲ trial to compare efficacy and safety of Goserelin Acetate Sustained-Release Microspheres for Injection (LY01005) and ZOLADEX® in patients with breast cancer.

Timeline

Start

2020-10-15

Primary completion

2022-04-05

Completion

2022-06-24

Drugs

Indications